Searched for
SYNGENE INTERNATIONAL SHARES
LIC dividend alert! Last day to buy insurance behemoth’s shares for Rs 10 dividendLIC has fixed June 25 as the record date for its Rs 10 final dividend, making today the last opportunity for investors to buy shares to qua...- Dividends & bonus issues: LIC, Asian Paints among 35 stocks turning ex-record date this week. How many do you own?Around 35 companies, including LIC, HUL, Asian Paints and IndusInd Bank, have fixed record dates for dividends, bonus issues and buybacks i...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended sharply lower as weak global cues and geopolitical tensions triggered broad-based selling. Nifty slipped 1.04% to 23,...
- Two Trades for Today: A biopharma firm for a 7.65% rise, a mid-cap healthcare stock for an upmove of about 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: ReportBiocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- FIIs slash stakes in 8 stocks over two quarters, shares crack up to 50%. Are you holding any?FIIs have steadily reduced their stakes in about 104 companies over the past two quarters, December 2025 (October–December) and March 2026 ...
- Stock Radar: Syngene International showing signs of momentum after falling 26% from highs; what should investors do?Syngene International stock is showing positive signs. The stock has recovered after hitting a 52-week low. It is trading above several key...
- Syngene International shares in focus after positive USFDA updates for 2 Bengaluru facilitiesSyngene International shares:The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Sem...
- Syngene International shares slump 10% after Q4 profit dips despite revenue growthSyngene International's shares plummeted 10% following a reported 3% year-on-year decline in consolidated net profit for Q4 FY25, despite a...
- Stock Radar: Syngene trades near crucial 100-EMA, down 10% from highs; time to buy?Syngene International's stock is displaying an Ascending Triangle pattern on the daily chart, a bullish signal that suggests the potential ...
- Syngene International Q3 Results: Net profit rises 2% YoY to Rs 112 crore, company revises revenue guidanceThe rise in Q3 profit of Syngene International was led by dedicated centres and development and manufacturing services, even as discovery s...
- Buy Syngene International, target price Rs 880: IIFLPromoters held 54.8 per cent stake in the company as of 30-Jun-2023, while FIIs owned 23.19 per cent, DIIs 11.2 per cent.
- Syngene International skids 4% as Q4 PAT declines 8% YoYOn a standalone basis, the company’s quarterly net profit stood at Rs 147 crore in March 2022, down 8.41 per cent from Rs 160.50 crore in M...
- Syngene International shares jump 5% after Q4 earningsThe company on Wednesday reported a 20 per cent rise in its consolidated net profit to Rs 120 crore for the quarter ended March 31, 2020, d...
- Trending stocks: Syngene International shares gain over 2%Shares of Syngene International Ltd. traded 2.43 per cent up in trade at 11:06AM on Thursday.
- Add Syngene International, target Rs 650: Yes SecuritiesAdd Syngene International at a price target of Rs 650.
- Buy Syngene International, target Rs 675: ICICI DirectBuy Syngene International at a price target of Rs 675.
- Biocon sells 1.88% stake in Syngene for Rs 230 croreIn a separate filing, Syngene said Biocon has sold the shares for achieving minimum public shareholding requirement.
Load More
